NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Jan 19, 2017
Insider Transaction Report
Form 4
GOLDBERG MICHAEL M
Director
Transactions
- Exercise of In-Money
Warrants (Right to Buy)
2017-01-17−5,411,850→ 0 totalExercise: $0.01From: 2016-10-17Exp: 2035-08-20→ Common Stock (5,411,850 underlying) - Exercise of In-Money
NAVB Common Stock, $.001 par value
2017-01-17$0.01/sh+5,411,850$54,119→ 5,815,002 total
Footnotes (1)
- [F1]Series LL warrants exercised in exchange for issuance of common stock.